Atlas Trials

Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma

Clinical trial NCT00372905 · TERMINATED

Trial details

NCT number
NCT00372905
Sponsor
Northwestern University
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2007-07-24
Primary completion
2010-06-22
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.